Sunil Patel

Sunil Patel is an experienced executive in the pharmaceutical industry, currently serving as Executive Director of BD Transactions focusing on Immunology, Cardiovascular, and Neuroscience, as well as leading Brand Divestitures and Manufacturing Facility Transactions at Bristol Myers Squibb. Previous roles at Bristol Myers Squibb include leadership in International Policy and Government Affairs, operations planning for the Intercontinental Region, and management of distributor markets and geographic optimization. Additionally, Sunil Patel has served as Associate Director for both the Global HIV Access Program and Supply Chain Analysis. Prior to joining Bristol Myers Squibb, Sunil Patel held the position of VP of Business Development and Marketing at Enerdyne Technologies. Sunil Patel's educational background includes an MBA in Operations from the Cornell Johnson Graduate School of Management and a BS in Industrial and Systems Engineering from The Ohio State University.